(Q37815479)

23 August 2017

1 reference

title

The rise and rise of stealth nanocarriers for cancer therapy: passive versus active targeting (English)

1 reference

23 August 2017

1 reference

Ngoc Trinh Huynh

1

1 reference

23 August 2017

Emilie Roger

2

1 reference

23 August 2017

Nolwenn Lautram

3

1 reference

23 August 2017

Jean-Pierre Benoît

4

1 reference

23 August 2017

Catherine Passirani

5

1 reference

23 August 2017

publication date

1 November 2010

1 reference

23 August 2017

1 reference

23 August 2017

volume

5

1 reference

23 August 2017

issue

9

1 reference

23 August 2017

page(s)

1415-1433

1 reference

Nanoparticle-based targeted drug delivery

23 August 2017

cites work

1 reference

https://api.crossref.org/works/10.2217%2FNNM.10.113

Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.10.113

Poly(ethylene glycol)-modified nanocarriers for tumor-targeted and intracellular delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.10.113

Long-circulating DNA lipid nanocapsules as new vector for passive tumor targeting

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.10.113

Progress in developing cationic vectors for non-viral systemic gene therapy against cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.10.113

Non-viral nanosystems for systemic siRNA delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.10.113

3D microvascular architecture of pre-cancerous lesions and invasive carcinomas of the colon

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.10.113

Control of tumour vascular permeability

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.10.113

Drug delivery and transport to solid tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.10.113

Regulation of transport pathways in tumor vessels: role of tumor type and microenvironment

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.10.113

Role of nanotechnology in targeted drug delivery and imaging: a concise review

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.10.113

Parameters influencing the stealthiness of colloidal drug delivery systems

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.10.113

Polysaccharide-decorated nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.10.113

Influence of polysaccharide coating on the interactions of nanoparticles with biological systems

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.10.113

Long-circulating polymeric nanovectors for tumor-selective gene delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.10.113

Targeting nanoparticles to cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.10.113

Receptor-mediated endocytosis of antibody-opsonized liposomes by tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.10.113

21 January 2018

The taxanes: an update

1 reference

https://api.crossref.org/works/10.2217%2FNNM.10.113

Cremophor EL: the drawbacks and advantages of vehicle selection for drug formulation

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.10.113

Role of formulation vehicles in taxane pharmacology

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.10.113

Paclitaxel and its formulations

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.10.113

Protein nanoparticles as drug carriers in clinical medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.10.113

In vivo evaluation of polymeric micellar paclitaxel formulation: toxicity and efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.10.113

Phase I and pharmacokinetic study of Genexol-PM, a cremophor-free, polymeric micelle-formulated paclitaxel, in patients with advanced malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.10.113

Phase II clinical trial of paclitaxel loaded polymeric micelle in patients with advanced pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.10.113

Multicenter phase II trial of Genexol-PM, a Cremophor-free, polymeric micelle formulation of paclitaxel, in patients with metastatic breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.10.113

Advances of cancer therapy by nanotechnology

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.10.113

Cardiovascular complications of cancer therapy: diagnosis, pathogenesis, and management

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.10.113

Role of pegylated liposomal doxorubicin in ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.10.113

Caelyx (stealth liposomal doxorubicin) in the treatment of advanced breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.10.113

Pharmacokinetics of pegylated liposomal Doxorubicin: review of animal and human studies

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.10.113

Clinical pharmacology of liposomal anthracyclines: focus on pegylated liposomal Doxorubicin

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.10.113

Pegylated liposomal doxorubicin: metamorphosis of an old drug into a new form of chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.10.113

Metastatic breast cancer: the role of pegylated liposomal doxorubicin after conventional anthracyclines

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.10.113

Cancer of the gastroesophageal junction: Current therapy options

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.10.113

Comparative pharmacokinetics, tissue distribution, and therapeutic effectiveness of cisplatin encapsulated in long-circulating, pegylated liposomes (SPI-077) in tumor-bearing mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.10.113

A phase I study in paediatric patients to evaluate the safety and pharmacokinetics of SPI-77, a liposome encapsulated formulation of cisplatin

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.10.113

A phase II study of STEALTH cisplatin (SPI-77) in patients with advanced non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.10.113

Phase I and pharmacokinetic study of SPI-77, a liposomal encapsulated dosage form of cisplatin

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.10.113

Phase II study of SPI-77 (sterically stabilised liposomal cisplatin) in advanced non-small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.10.113

Plasma, tumor, and tissue disposition of STEALTH liposomal CKD-602 (S-CKD602) and nonliposomal CKD-602 in mice bearing A375 human melanoma xenografts

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.10.113

Pharmacokinetic study of pegylated liposomal CKD-602 (S-CKD602) in patients with advanced malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.10.113

Drug delivery systems: entering the mainstream

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.10.113

Polymeric drugs for efficient tumor-targeted drug delivery based on EPR-effect

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.10.113

Nanocarriers as an emerging platform for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.10.113

Enhanced permeability and retention of macromolecular drugs in solid tumors: a royal gate for targeted anticancer nanomedicines.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.10.113

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.10.113

High interstitial fluid pressure - an obstacle in cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.10.113

Degradable and bioresorbable polymers in surgery and in pharmacology: beliefs and facts

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.10.113

Therapeutic synthetic polymers: a game of Russian roulette?

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.10.113

Nanoparticles evading the reticuloendothelial system: role of the supported bilayer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.10.113

Long-circulating polymeric nanoparticles bearing a combinatorial coating of PEG and water-soluble chitosan

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.10.113

Accelerated blood clearance (ABC) phenomenon upon repeated injection of PEGylated liposomes

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.10.113

Immunogenicity and rapid blood clearance of liposomes containing polyethylene glycol-lipid conjugates and nucleic Acid

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.10.113

Brain delivery property and accelerated blood clearance of cationic albumin conjugated pegylated nanoparticle

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.10.113

Particle size-dependent triggering of accelerated blood clearance phenomenon

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.10.113

Enzymatic degradation of liposome-grafted poly(hydroxyethyl L-glutamine).

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.10.113

Effects of cleavable PEG-cholesterol derivatives on the accelerated blood clearance of PEGylated liposomes

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.10.113

Intravenous administration to rabbits of non-stealth and stealth doxorubicin-loaded solid lipid nanoparticles at increasing concentrations of stealth agent: pharmacokinetics and distribution of doxorubicin in brain and other tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.10.113

Polymer conjugates as anticancer nanomedicines

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.10.113

Preparation, characterization, cytotoxicity and pharmacokinetics of liposomes containing docetaxel

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.10.113

Active targeting schemes for nanoparticle systems in cancer therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.10.113

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.10.113

Active targeting with particulate drug carriers in tumor therapy: fundamentals and recent progress

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.10.113

Ligand-targeted therapeutics in anticancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.10.113

New approaches to antibody therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.10.113

Enhanced cytotoxicity of monoclonal anticancer antibody 2C5-modified doxorubicin-loaded PEGylated liposomes against various tumor cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.10.113

Monoclonal antibody 2C5-modified doxorubicin-loaded liposomes with significantly enhanced therapeutic activity against intracranial human brain U-87 MG tumor xenografts in nude mice

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.10.113

Engineering of therapeutic antibodies to minimize immunogenicity and optimize function

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.10.113

Preparation and Characterization of Paclitaxel-loaded PLGA nanoparticles coated with cationic SM5-1 single-chain antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.10.113

A nanoparticle-based model delivery system to guide the rational design of gene delivery to the liver. 1. Synthesis and characterization

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.10.113

Nanocrystal targeting in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.10.113

Surface-engineered nanoparticles for multiple ligand coupling

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.10.113

Active targeting of brain tumors using nanocarriers

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.10.113

Aptamers: an emerging class of therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.10.113

Aptamers as tools for target validation

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.10.113

Nanoparticle-aptamer bioconjugates: a new approach for targeting prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.10.113

Targeted nanoparticle-aptamer bioconjugates for cancer chemotherapy in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.10.113

Formulation of functionalized PLGA-PEG nanoparticles for in vivo targeted drug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.10.113

RGD-based strategies for selective delivery of therapeutics and imaging agents to the tumour vasculature

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.10.113

Anti-tumor efficacy of tumor vasculature-targeted liposomal doxorubicin

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.10.113

Tissue-penetrating delivery of compounds and nanoparticles into tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.10.113

New frontiers in nanotechnology for cancer treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.10.113

Folate-mediated targeting of antineoplastic drugs, imaging agents, and nucleic acids to cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.10.113

Therapeutic applications of colloidal drug carriers

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.10.113

Galactosylated DNA lipid nanocapsules for efficient hepatocyte targeting

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.10.113

Nanoparticles in cellular drug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.10.113

Targeting of drugs and nanoparticles to tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.10.113

Multifunctional and stimuli-sensitive pharmaceutical nanocarriers

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.10.113

Polymers and nanoparticles: intelligent tools for intracellular targeting?

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.10.113

Synthesis and pH-dependent micellization of diblock copolymer mixtures

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.10.113

Extracellularly activated nanocarriers: a new paradigm of tumor targeted drug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.10.113

Influence of poly(ethylene glycol) grafting density and polymer length on liposomes: relating plasma circulation lifetimes to protein binding.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.10.113

Enhanced solubility and stability of PEGylated liposomal paclitaxel: in vitro and in vivo evaluation

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.10.113

Direct measurement of the extravasation of polyethyleneglycol-coated liposomes into solid tumor tissue by in vivo fluorescence microscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.10.113

Novel long-circulating lipid nanocapsules

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.10.113

Long circulating poly(ethylene glycol)-decorated lipid nanocapsules deliver docetaxel to solid tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.10.113

Pegylated nanocapsules produced by an organic solvent-free method: Evaluation of their stealth properties.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.10.113

In vitro and in vivo evaluation of methoxy polyethylene glycol-polylactide (MPEG-PLA) nanoparticles for small-molecule drug chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.10.113

Long-circulating poly(ethylene glycol)-poly(D,L-lactide) block copolymer micelles with modulated surface charge

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.10.113

PEGylated PLGA nanoparticles for the improved delivery of doxorubicin

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.10.113

PEGylated PLGA nanoparticles as protein carriers: synthesis, preparation and biodistribution in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.10.113

Paclitaxel-loaded PEGylated PLGA-based nanoparticles: in vitro and in vivo evaluation

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.10.113

Anticancer activity of cisplatin-loaded PLGA-mPEG nanoparticles on LNCaP prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.10.113

Stealth PEGylated polycyanoacrylate nanoparticles for intravenous administration and splenic targeting

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.10.113

Body distribution and in situ evading of phagocytic uptake by macrophages of long-circulating poly (ethylene glycol) cyanoacrylate-co-n-hexadecyl cyanoacrylate nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.10.113

Long-circulating PEGylated polycyanoacrylate nanoparticles as new drug carrier for brain delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.10.113

Poly(ethylene glycol)-coated hexadecylcyanoacrylate nanospheres display a combined effect for brain tumor targeting

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.10.113

Low-density lipoprotein receptor-mediated endocytosis of PEGylated nanoparticles in rat brain endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.10.113

Translocation of poly(ethylene glycol-co-hexadecyl)cyanoacrylate nanoparticles into rat brain endothelial cells: role of apolipoproteins in receptor-mediated endocytosis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.10.113

Camptothecin derivative-loaded poly(caprolactone-co-lactide)-b-PEG-b-poly(caprolactone-co-lactide) nanoparticles and their biodistribution in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.10.113

10-Hydroxycamptothecin loaded nanoparticles: preparation and antitumor activity in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.10.113

Poly(epsilon-caprolactone)/poly(ethylene glycol)/poly(epsilon-caprolactone) nanoparticles: preparation, characterization, and application in doxorubicin delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.10.113

ABA and BAB type triblock copolymers of PEG and PLA: a comparative study of drug release properties and "stealth" particle characteristics.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.10.113

A Novel Family ofl-Amino Acid-Based Biodegradable Polymer−Lipid Conjugates for the Development of Long-Circulating Liposomes with Effective Drug-Targeting Capacity

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.10.113

New amphipatic polymer-lipid conjugates forming long-circulating reticuloendothelial system-evading liposomes

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.10.113

Doxorubicin-incorporated nanoparticles composed of poly(ethylene glycol)-grafted carboxymethyl chitosan and antitumor activity against glioma cells in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.10.113

The effect of surface functionalization of PLGA nanoparticles by heparin- or chitosan-conjugated Pluronic on tumor targeting

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.10.113

Novel polysaccharide-decorated poly(isobutyl cyanoacrylate) nanoparticles.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.10.113

Antitumor effect of paclitaxel-loaded PEGylated immunoliposomes against human breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.10.113

Arg-Gly-Asp (RGD) peptide conjugated poly(lactic acid)-poly(ethylene oxide) micelle for targeted drug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.10.113

Intracellular delivery of doxorubicin with RGD-modified sterically stabilized liposomes for an improved antitumor efficacy: in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.10.113

Enhanced intracellular delivery and improved antitumor efficacy of doxorubicin by sterically stabilized liposomes modified with a synthetic RGD mimetic

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.10.113

Folate receptor targeted biodegradable polymeric doxorubicin micelles

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.10.113

Self-assembled nanoparticles based on glycol chitosan bearing hydrophobic moieties as carriers for doxorubicin: in vivo biodistribution and anti-tumor activity

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.10.113

Development of a highly stable and targetable nanoliposomal formulation of topotecan

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.10.113

Novel drug delivery systems for sustained and targeted delivery of anti- cancer drugs: current status and future prospects

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.10.113

A phase I and pharmacokinetic study of NK105, a paclitaxel-incorporating micellar nanoparticle formulation

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.10.113

Emerging nanomedicines for early cancer detection and improved treatment: current perspective and future promise

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.10.113

Use of liposomal anthracyclines in Kaposi's sarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.10.113

Pegylated liposomal doxorubicin: optimizing the dosing schedule in ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.10.113

Phase I clinical trial and pharmacokinetic evaluation of NK911, a micelle-encapsulated doxorubicin

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.10.113

Antitumor effect of MCC-465, pegylated liposomal doxorubicin tagged with newly developed monoclonal antibody GAH, in colorectal cancer xenografts

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.10.113

Phase I and pharmacokinetic study of MCC-465, a doxorubicin (DXR) encapsulated in PEG immunoliposome, in patients with metastatic stomach cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.10.113

Clinical overview on Lipoplatin: a successful liposomal formulation of cisplatin

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.10.113

Cisplatin-incorporating polymeric micelles (NC-6004) can reduce nephrotoxicity and neurotoxicity of cisplatin in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.10.113

Phase I and pharmacokinetic study of pegylated liposomal CKD-602 in patients with advanced malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.10.113

Preclinical and clinical studies of anticancer agent-incorporating polymer micelles

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.10.113

Antibody-Conjugated Nanoparticles for Biomedical Applications

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.10.113

Targeting to cells of fluorescent liposomes covalently coupled with monoclonal antibody or protein A

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.10.113

21 January 2018

Identifiers

DOI

10.2217/NNM.10.113

1 reference

release_4hwdwzttufeu3mbflo5xeutcke

23 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/4hwdwzttufeu3mbflo5xeutcke

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference